Zobrazeno 1 - 10
of 349
pro vyhledávání: '"D O, Cosgrove"'
Autor:
Marvin C. Ziskin
Publikováno v:
The Journal of the Acoustical Society of America. 66:1570-1571
Autor:
Albert Goldstein
Publikováno v:
Medical Physics. 7:267-268
Autor:
Kazam, E.
Publikováno v:
Clinical Imaging; 1995, Vol. 19 Issue: 4 p289-289, 1p
Autor:
Gavin Hamilton, William Vennart, H.C. Thomas, Julie Fitzpatrick, D. O. Cosgrove, Mary M.E. Crossey, Robert J. Eckersley, Simon D. Taylor-Robinson, Robert D. Goldin, N. Patel, Adrian Lim
Publikováno v:
Journal of Viral Hepatitis. 18:e530-e534
We compared in vivo hepatic (31) P magnetic resonance spectroscopy ((31) P MRS) and hepatic vein transit times (HVTT) using contrast-enhanced ultrasound with a microbubble agent to assess the severity of hepatitis C virus (HCV)-related liver disease.
Autor:
Robert J. Eckersley, D. O. Cosgrove, Simon D. Taylor-Robinson, M. J. K. Blomley, J. M. Pilcher, Claire L. Shovlin, N. Patel, Adrian Lim
Publikováno v:
Ultrasound. 13:100-105
Hepatopulmonary syndrome (HPS) may cause profound symptomatic hypoxia in patients with chronic liver disease and can be an indication for liver transplantation. The diagnosis relies on the demonstration of intrapulmonary vascular dilatation (IVD) usi
Autor:
Raffaella Basilico, A. Urbank, A. Lim, Chris J Harvey, M. J. K. Blomley, D. O. Cosgrove, Rolf A. Heckemann, Robert J. Eckersley, N. Patel, Simon D. Taylor-Robinson
Publikováno v:
Gut. 52:1188-1193
Background: A previous pilot study showed that early arrival time of a microbubble in a hepatic vein is a sensitive indicator of cirrhosis. Aim: To see if this index can also grade diffuse liver disease. Patients: Thirty nine fasted patients with his
Publikováno v:
BJU International. 86:11-17
Autor:
D. O. Cosgrove, A. Urbank, Marianne Mahler, Thomas Albrecht, Reinhard Schlief, C. J. Dore, A. Bauer, M. J. K. Blomley
Publikováno v:
Radiology. 207:339-347
PURPOSE: To investigate whether continuous infusion of an echo-enhancing contrast agent for up to 15 minutes can provide uniform and prolonged enhancement. MATERIALS AND METHODS: Six volunteers each received one bolus and three infusions of a microbu
Autor:
M, Claudon, C F, Dietrich, B I, Choi, D O, Cosgrove, M, Kudo, C P, Nolsøe, F, Piscaglia, S R, Wilson, R G, Barr, M C, Chammas, N G, Chaubal, M-H, Chen, D A, Clevert, J M, Correas, H, Ding, F, Forsberg, J B, Fowlkes, R N, Gibson, B B, Goldberg, N, Lassau, E L S, Leen, R F, Mattrey, F, Moriyasu, L, Solbiati, H-P, Weskott, H-X, Xu
Initially, a set of guidelines for the use of ultrasound contrast agents was published in 2004 dealing only with liver applications. A second edition of the guidelines in 2008 reflected changes in the available contrast agents and updated the guideli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c16429724c245058f02d1031c28492a1
http://hdl.handle.net/11585/144897
http://hdl.handle.net/11585/144897
Autor:
A K P, Lim, N, Patel, R J, Eckersley, J, Fitzpatrick, M M E, Crossey, G, Hamilton, R D, Goldin, H C, Thomas, W, Vennart, D O, Cosgrove, S D, Taylor-Robinson
Publikováno v:
Journal of viral hepatitis. 18(10)
We compared in vivo hepatic (31) P magnetic resonance spectroscopy ((31) P MRS) and hepatic vein transit times (HVTT) using contrast-enhanced ultrasound with a microbubble agent to assess the severity of hepatitis C virus (HCV)-related liver disease.